276D: Substitutions At C2' Of Daunosamine In The Anticancer Daunor Alter Its Dna-Binding Sequence Specificity
reference: Substitutions at C2' of daunosamine in the anticancer drug daunorubicin alter its DNA-binding sequence specificity., Gao YG, Priebe W, Wang AH, Eur J Biochem 1996 Sep 1;240(2):331-5. PMID: 8841395

This OCA Structure page
uses Jmol, developed by the Jmol Development Team (documentation).